Ji, X.* ; Mukherjee, S.* ; Landi, M.T.* ; Bosse, Y.* ; Joubert, P.* ; Zhu, D.* ; Gorlov, I.* ; Xiao, X.* ; Han, Y.* ; Gorlova, O.* ; Hung, R.J.* ; Brhane, Y.* ; Carreras-Torres, R.* ; Christiani, D.C.* ; Caporaso, N.* ; Johansson, M.* ; Liu, G.* ; Bojesen, S.E.* ; Le Marchand, L.* ; Albanes, D.* ; Bickeböller, H.* ; Aldrich, M.C.* ; Bush, W.S.* ; Tardón, A.* ; Rennert, G.* ; Chen, C.* ; Byun, J.* ; Dragnev, K.H.* ; Field, J.K.* ; Kiemeney, L.F.* ; Lazarus, P.* ; Zienolddiny, S.* ; Lam, S.* ; Schabath, M.B.* ; Andrew, A.S.* ; Bertazzi, P.A.* ; Pesatori, A.C.* ; Diao, N.* ; Su, L.* ; Song, L.* ; Zhang, R.* ; Leighl, N.* ; Johansen, J.S.* ; Mellemgaard, A.* ; Saliba, W.* ; Haiman, C.* ; Wilkens, L.* ; Fernández-Somoano, A.* ; Fernandez-Tardon, G.* ; Heijden, E.H.F.M.v.d.* ; Kim, J.H.* ; Davies, M.P.A.* ; Marcus, M.W.* ; Brunnström, H.* ; Manjer, J.* ; Melander, O.* ; Müller, D.C.* ; Overvad, K.* ; Trichopoulou, A.* ; Tumino, R.* ; Goodman, G.E.* ; Cox, A.* ; Taylor, F.* ; Woll, P.* ; Wichmann, H.-E. ; Muley, T.* ; Risch, A.* ; Rosenberger, A.* ; Grankvist, K.* ; Shepherd, F.A.* ; Tsao, M.S.* ; Arnold, S.M.* ; Haura, E.B.* ; Bolca, C.* ; Holcatova, I.* ; Janout, V.* ; Kontic, M.* ; Lissowska, J.* ; Mukeria, A.* ; Ognjanovic, S.* ; Orlowski, T.M.* ; Scelo, G.* ; Swiatkowska, B.* ; Zaridze, D.* ; Bakke, P.* ; Skaug, V.* ; Butler, L.M.* ; Offit, K.* ; Srinivasan, P.* ; Bandlamudi, C.* ; Hellmann, M.D.* ; Solit, D.B.* ; Robson, M.E.* ; Rudin, C.M.* ; Stadler, Z.K.* ; Taylor, B.S.* ; Berger, M.F.* ; Houlston, R.* ; McLaughlin, J.*
Protein-altering germline mutations implicate novel genes related to lung cancer development.
Nat. Commun. 11:2220 (2020)
Few germline mutations are known to affect lung cancer risk. We performed analyses of rare variants from 39,146 individuals of European ancestry and investigated gene expression levels in 7,773 samples. We find a large-effect association with an ATM L2307F (rs56009889) mutation in adenocarcinoma for discovery (adjusted Odds Ratio=8.82, P=1.18x10(-15)) and replication (adjusted OR=2.93, P=2.22x10(-3)) that is more pronounced in females (adjusted OR=6.81 and 3.19 and for discovery and replication). We observe an excess loss of heterozygosity in lung tumors among ATM L2307F allele carriers. L2307F is more frequent (4%) among Ashkenazi Jewish populations. We also observe an association in discovery (adjusted OR=2.61, P=7.98x10(-22)) and replication datasets (adjusted OR=1.55, P=0.06) with a loss-of-function mutation, Q4X (rs150665432) of an uncharacterized gene, KIAA0930. Our findings implicate germline genetic variants in ATM with lung cancer susceptibility and suggest KIAA0930 as a novel candidate gene for lung cancer risk. In lung cancer, relatively few germline mutations are known to impact risk. Here the authors looked at rare variants in 39,146 individuals and find novel germline mutations associated with risk, as well as implicating ATM and a new candidate gene for lung cancer risk.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Association; Susceptibility; Expression; Prediction; Brca1
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2020
Prepublished im Jahr
HGF-Berichtsjahr
2020
ISSN (print) / ISBN
2041-1723
e-ISSN
2041-1723
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 11,
Heft: 1,
Seiten: ,
Artikelnummer: 2220
Supplement: ,
Reihe
Verlag
Nature Publishing Group
Verlagsort
London
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Epidemiology (EPI)
POF Topic(s)
30202 - Environmental Health
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-504000-009
Förderungen
Copyright
Erfassungsdatum
2020-06-08